L2 DIAGNOSTICS

L2 is a biotechnology company based in New Haven, Connecticut, USA with focus on new small molecule therapeutics, vaccines, and diagnostics... L 2 was founded in 1998 as a provider of novel diagnostic services for systemic lupus erythematosus and Lyme disease. The company rapidly evolved a new emphasis on developing novel diagnostic tools in a number of areas, discovering new vaccines and the development of small molecule therapeutics. Our current research activity is summarized on the Research page on this site... Many of our projects are supported by the National Institutes for Health, Department of Defense, and private foundations.

Primary location: New Haven United States